How Cat Cancer Research Helps Fight Human Tumors
Scientists mapped cancer genetics across nearly 500 cat tumors and found striking overlaps with human cancers, opening new paths for treatments that could benefit both species.
Your Cat's Cancer Looks a Lot Like Yours
Cats and humans share roughly 90 percent of their genomes. Now scientists have discovered that the overlap extends to cancer. A landmark study published in Science in February 2026 sequenced tumors from 493 domestic cats across 13 cancer types—and found that the genetic mutations driving feline cancers are strikingly similar to those found in human tumors.
The findings open a two-way street: treatments developed for people could help sick cats, and studying how cancer develops naturally in cats could accelerate drug discovery for humans.
What Is Comparative Oncology?
Comparative oncology is the study of naturally occurring cancers in animals—especially pets—to gain insights into human disease. Unlike lab mice engineered to grow tumors, cats and dogs develop cancer spontaneously, live in the same households as their owners, breathe the same air, and face many of the same environmental risks. That makes their tumors far more realistic models of how cancer behaves in people.
The field rests on a simple premise: evolution conserved many of the same genes across mammals. When those genes go wrong, the resulting cancers often look remarkably alike at the molecular level.
What the Feline Cancer Genome Revealed
The international team—led by Louise van der Weyden at the Wellcome Sanger Institute and including researchers from Cornell University, the University of Guelph, and the University of Bern—collected tumor samples from cats in five countries. They identified 31 driver genes, the key mutations that push cells toward uncontrolled growth.
The most frequently mutated gene was TP53, altered in 33 percent of feline tumors. In human cancers, TP53 mutations appear at nearly the same rate—about 34 percent. Another gene, FBXW7, was altered in more than half of feline mammary carcinomas. In humans, FBXW7 mutations are linked to worse outcomes in breast cancer.
Parallels extended across blood cancers, bone sarcomas, lung tumors, skin cancers, gastrointestinal tumors, and central nervous system malignancies. UV-induced skin cancers in cats even demonstrated the same environmental mutation signatures seen in humans.
Why Cats Make Unusually Good Cancer Models
Cats offer several advantages over traditional laboratory models:
- Natural tumors. Feline cancers arise spontaneously, not from artificial genetic manipulation, so they better reflect real disease progression.
- Shared environment. Indoor cats are exposed to the same household chemicals, air quality, and lifestyle factors as their owners.
- Aggressive disease. The vast majority of mammary tumors in cats are malignant, and the triple-negative phenotype is more common than in humans, providing a concentrated population for studying the hardest-to-treat subtypes.
- Shorter lifespan. Cancers progress faster in cats, allowing researchers to collect outcome data in months rather than years.
Feline oral squamous cell carcinoma, which accounts for 70–80 percent of oral tumors in cats, closely mirrors human head and neck cancer at the molecular level—including overexpression of the epidermal growth factor receptor (EGFR), a common drug target.
From Lab to Clinic—for Both Species
"We can utilize information found in people and translate that to cats, and also from cats to humans," said Dr. Latasha Ludwig of Cornell University's College of Veterinary Medicine. The team's data is now freely available to researchers worldwide.
Chemotherapy treatments already showed higher efficacy against feline tumors carrying FBXW7 mutations, hinting that genetic profiling could guide therapy choices for cats just as it increasingly does for human patients. This "One Health" approach—treating animal and human medicine as interconnected—could shorten the path from lab bench to bedside for both species.
Cancer remains a leading cause of death in companion animals, yet feline oncology has historically received far less funding than canine research. With a comprehensive genetic atlas now in hand, that gap may finally begin to close—and in the process, help humans too.
